Patient‐reported postoperative pain, body image, and cosmetic satisfaction after transumbilical laparoendoscopic single‐site adrenalectomy

Nomura, Takeo; Takei, Kuniharu; Abe, Satoki; Fukuda, Yuko; Yamanaka, Naoyuki; Sejiyama, Shinya; Yamasaki, Mutsushi; Shibuya, Tomoyoshi; Ando, Tadasuke; Mori, Kenichi; Sumino, Yasuhiro; Sato, Fuminori; Mimata, Hiromitsu

doi:10.1111/ases.12361

Cited by 6 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ [36] , [37] , [38] ] Reducing postoperative pain and opioid use can prevent postoperative ileus, and early postoperative oral feeding can shorten hospital stay and facilitate faster recovery [ [44] , [45] , [46] , [47] , [48] ]. Cosmesis is one of the advantages of single-site incision laparoscopic surgery, and it is associated with body image and self-esteem [ 49 , 50 ]. Four included studies reported aesthetic outcomes, but no standardized measurement tools were employed to evaluate them.…”

Section: Discussionmentioning

confidence: 99%

Laparoendoscopic single-site adrenalectomy versus multi-port laparoendoscopic adrenalectomy: A systemic review and meta-analysis

Kang

et al. 2021

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Background To investigate the outcomes of laparoendoscopic single-site adrenalectomy (LESS-A) compared to multi-port laparoendoscopic adrenalectomy (m-LA). Methods Studies comparing LESS-A with m-LA were identified from PubMed, Embase, and Cochrane Library before June 2020. Post-operative pain, resumption outcomes, and perioperative outcomes were analyzed. We conducted meta-analyses using the Mantel-Haenszel method with random-effects model. Subset analyses were conducted according to peritoneal and retroperitoneal approaches. A small study effect was illustrated using funnel plots and Egger's test. Results One randomized controlled trial (RCT) and nineteen retrospective cohort studies involving 1554 patients were included for analyzed. Pooled analysis showed that LESS-A had significantly lower postoperative pain scores (MD −0.77, 95%CI −1.45 to −0.10) and less pain medication used (RR 0.74, 95%CI 0.60 to 0.91) compared to m-LA. Besides, LESS-A had significantly shorter hospital stays (MD −0.75, 95%CI −1.18 to −0.33), shorter duration of oral intake resumption (MD −0.33, 95%CI −0.60 to −0.06), and better cosmetic satisfaction (SMD 1.15, 95%CI 0.21 to −2.09). As for perioperative outcomes, LESS-A led to significant longer operative time (MD 13.43, 95%CI 4.08 to 22.77). No significant differences were observed in terms of the remaining perioperative outcomes. Conclusions LESS-A is associated with less post-operative pain and quicker recovery duration. However, the longer operative time of LESS-A compared with m-LA is a drawback.

show abstract

Section: Discussionmentioning

confidence: 99%

Laparoendoscopic single-site adrenalectomy versus multi-port laparoendoscopic adrenalectomy: A systemic review and meta-analysis

Kang

et al. 2021

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

show abstract

“…Patients have to suffer pain during titration, which severely reduces the satisfaction. 5 To understand the feasibility of PCIA technology for opiate titration in patients with severe cancer, we used PCIA technology for opiate titration in patients with severe cancer. The shorter time needed in this study may be due to the need for multiple assessments and administrations during oral, subcutaneous, or intravenous titration, and in particular the substantial increase in the workload of the health care workers by injection.…”

Section: Discussionmentioning

confidence: 99%

Rapid titration of opiate doses via patient-controlled intravenous analgesia for patients with severe cancer pain

et al. 2018

View full text Add to dashboard Cite

This study was to investigate the feasibility and safety of patient-controlled intravenous analgesia for opiate titration in patients with severe cancer. Eligible patients with cancer pain were randomly divided into two groups, which were titrated with a subcutaneous injection of morphine and patient-controlled intravenous analgesia, respectively. The time required for patients to begin titration to reach visual analog scale score ⩽ 3, the adverse reactions during titration, the time spent by nurses in titrating each patient, and the time to complete the titration with a delayed-release dosage form analgesic effect and adverse reaction. The mean titration time of patient-controlled intravenous analgesia group (1.09 ± 0.82 vs 2.97 ± 1.98) and morphine dosage (18.78 ± 12.32 vs 13.23 ± 8.07) were significantly lower than those in the subcutaneous group (P < 0.05). The incidences of nausea, vomiting, pruritus, urinary retention, and sedation in the subcutaneous injection group were significantly lower than those in the subcutaneous injection group (P < 0.05). The assessment times of the two groups (10.19 ± 3.72 vs 10.25 ± 4.88) were similar (P > 0.05). However, the time required for subcutaneous injection in patients under patient-controlled intravenous analgesia was significantly lower than that in the subcutaneous injection group (36.36 ± 12.15 vs 132.36 ± 32.79), which was statistically significant (P < 0.05). After the titration, the controlled release opioid was used to treat cancer pain. The visual analog scale score of the patientcontrolled intravenous analgesia group was significantly lower than that of the subcutaneous group (2.44 ± 1.37 vs 2.73 ± 0.91) at 7 days after treatment in the subcutaneous group (1.05 ± 0.30 vs 2.45 ± 1.29; P < 0.05). Patient-controlled intravenous analgesia technique can effectively and quickly complete the titration of cancer pain treatment with less occupational care resources and is better than the subcutaneous injection titration.

show abstract

Laparoendoscopic single-site inguinal lymphadenectomy in gynecology: preliminary experience at a single institution

Duan

Guan

et al. 2020

Arch Gynecol Obstet

View full text Add to dashboard Cite

Patient‐reported postoperative pain, body image, and cosmetic satisfaction after transumbilical laparoendoscopic single‐site adrenalectomy

Abstract: Transumbilical LESS-A confers less postoperative pain and better cosmetic satisfaction than conventional laparoscopic adrenalectomy. Therefore, this procedure could potentially become a standard treatment option for benign adrenal tumors.

Cited by 6 publications

References 18 publications

Laparoendoscopic single-site adrenalectomy versus multi-port laparoendoscopic adrenalectomy: A systemic review and meta-analysis

Laparoendoscopic single-site adrenalectomy versus multi-port laparoendoscopic adrenalectomy: A systemic review and meta-analysis

Rapid titration of opiate doses via patient-controlled intravenous analgesia for patients with severe cancer pain

Laparoendoscopic single-site inguinal lymphadenectomy in gynecology: preliminary experience at a single institution

Contact Info

Product

Resources

About